TxBDC has published seven clinical trials since our founding in 2012.
Researchers from Baylor Scott & White Research Institute and the Texas Biomedical Device Center at The University of Texas at Dallas have teamed up to assess if implanted vagus nerve stimulation (VNS) can make Prolonged Exposure Therapy (a psychological treatment) more tolerable and effective for reducing symptom severity in participants with posttraumatic stress disorder (PTSD). Find out more
Researchers from Baylor Scott & White Institute for Rehabilitation and the Texas Biomedical Device Center at The University of Texas at Dallas have teamed up to assess if implanted vagus nerve stimulation (VNS) coupled with rehabilitation is able to improve recovery of arm function in people living with a spinal cord injury. Find out more
On June 3, 2020 we received FDA approval for the first in human study using the ReStore Vagus Nerve Stimulator to enhance recovery after stroke. TxBDC is currently in the planning stage of this clinical trial. Recruitment for this trial is anticipated to begin in the spring of 2021. If you would like to be notified when recruiting begins please send an email to [email protected].
Follow this link for information about our three published clinical trials in stroke.
We are not currently running any clinical trials for tinnitus. TxBDC conducted initial research and development into the VNS therapy for Tinnitus; after which one of our partner companies, MicroTransponder, further developed the technology and brought the treatment to clinical trials.
Further information regarding Tinnitus and VNS therapy can be found on MicroTransponder’s website.
Follow this link for information about our four published clinical trials in tinnitus.